Navigation Links
Pts in Medical News

Hydrogenated Fat Pts Weight around the Abdomen

According to a study it was found that hydrogenated fat or processed fat resulted in potbelly. These types of fats are used mainly in biscuits to cut manufacturing costs of foods and increase their shelf life //. They are found in abundance in pastry and ready meals. People put on weight especially...

For Many, 9/11-Linked Trauma Emerged Years Later

... said they had received no treatment in the preceding year. "As a local health department, we were most concerned and surprised by the increase in pts symptoms," Thorpe said. "We do know that getting appropriate trauma-specific care is critical so we're making as many efforts a possible to link peopl...

President's Council Projects Growth For Physical Therapy Profession

... pts and PTAs listed as occupations that will "likely g...ions that will "likely grow in importance" include pts and physical therapist assistants. In addition, th...pically acquired through post-secondary education. pts are required to receive a graduate degree - either...

New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes

... higher levels of activation rates correlate with improved self-care behaviors. In fact, the Hibbard study demonstrated that PAM scores increased 4.6 pts for the intervention group compared to just 1.4 points for the control group, demonstrating that the tool improved the patients' ability to manage the...

New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes

... higher levels of activation rates correlate with improved self-care behaviors. In fact, the Hibbard study demonstrated that PAM scores increased 4.6 pts for the intervention group compared to just 1.4 points for the control group, demonstrating that the tool improved the patients' ability to manage the...

Dialysis Corporation of America Reports First Quarter 2009 Results

... 2008 Key clinical metrics: Treatment adequacy (% of pts with Kt/V greater than 1.2) 97% ...Hgb greater than 11) 81% 82% Venous access (% of pts with AVF) 57% 56% ...

APTA's Multidisciplinary Summit Establishes Opportunities for Physical Therapists to Drive Health Care Change

...nd be willing to collaborate with them." - represent just a few of the quotable moments from the Summit. PASS produced agreement among participants - pts and non-PTs alike - that the physical therapy profession has a pivotal role in meeting society's health care needs, particularly in the area of preven...

Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31, 2008 Results

...trics: Treatment adequacy (% of pts with Kt/V greater than 1.2) 97.32% ... 95.38% Anemia management (% of pts with Hgb greater than 11) 82.06% ... 78.74% Venous access (% of pts with AVF) 56.06% 52.98% ...

Exercise underutilized for chronic back and neck pain

...a PT who did prescribe exercise. Not surprisingly, pts were the most likely to prescribe exercise, althou...to some extent, the types of exercises prescribed. pts were more likely to provide supervision and prescr...k. "Although exercise prescription provided by pts appears to be the most in line with current guidel...

La Rabida Children's Hospital's 13th Annual Symposium to Discuss Outcomes of Premature Birth

...r 5 hours of Early Intervention Credentialing Credits in varied areas of approval La Rabida Children's Hospital as continuing education sponsor for pts and OTs, 6 hours of credit. Penguin Project performance The Penguin Project, a Peoria-based peer mentoring group that involves children with disab...

More>>

Pts in Medical Technology

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... *blood measurements of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) Efficacy Results Treatment N of pts ACR 20 ACR 50 ACR 70 DAS28<2.6 --------- -------- ------ ------ ------ --------- Placebo ...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

... trials that we plan to launch with a corporate partner in the first half of next year, " he added. Efficacy Results Treatment N of pts ACR 20 ACR 50 ACR 70 DAS28<2.6 Placebo 153 53 (35%) 29 (19%) 16 (10%) 9 (6%) 150 mg qd 152 87 (57%)...

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

... Group N PR SD > 12 wks CBR* Median PFS N (%) N (%) N (%) (SD or >) All pts 46 5 (11%) 16 (35%) 21 (46%) 33 weeks [95% CI (24, 60)] *CBR: Clinical B...

Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs

...g, fatigue and/or skin ulcers. About 25- 50 percent of DVT patients develop pts when treated with blood thinners alone. While early treatment with blood th... early, before permanent damage to the vein occurs," he noted. "Established pts is a lifelong, irreversible condition for which there are no consistently e...

New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry

...dissolve on its own, but in the meantime the veins are permanently damaged. pts is caused by a combination of vein valve damage and blocked blood flow in t...ng obstruction or lesion that should be corrected to prevent a future clot. pts -- while not life threatening -- limits a person's ability to walk or stand...

US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium

...clophosphamide 500 mg/m2 all IV every 21 D x 4 cycles. Post ASCO '05, HER2+ pts received H (4 mg/kg on Day 1, then 2 mg/kg wkly x 12 wks). After FEC, wee...d left ventricular ejection fraction (LVEF) <50 percent occurred in 4 of 40 pts receiving FEC75+H but there was no heart failure & repeat LVEFs were >50 pe...

Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology

... PD after Peri + Vel 2 (13%) Rel/Refractory 5, 4 Stable disease (SD): **subject to confirmation *2 pts were inevaluable for response (removed from study after only 1 cycle of treatment) Times with '+' meaning patient still...

Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium

...r phase 2 trials underway evaluating perifosine 100 mg as a single agent in pts who have failed a prior TKI (sunitinib or sorafenib), with one of the studies allowing pts who have also failed prior mTOR. Data from these phase 2 TKI failure studie...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

...ct to IV therapy (ATS guidelines) in vent pts with gram-neg pneumonia, 12 pts received ...a the PDDS, (Nektar Therapeutics) in vent pts with gram-neg pneumonia adjunctive to IV antibiotic therapy (ATS guidelines). pts randomized to aerosol with 400 mg AMK QD ...

New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel

...yelodysplastic syndromes -- Thomas Hutson, D.O., PharmD, Associate Chair, GU Cancer, US Oncology Research: Pazopanib (PAZ, GW786034) in pts w/ metastatic Renal Cell Carcinoma (RCC): Interim results of a PH II Randomized Discontinuation Trial (RDT) -- Guru Sonpavde, M....
Pts in Medical Dictionary

DPT

...f Physical Therapy ( DPT ) About the Program. News. Welcome from the Program Chair ... We also offer an "advanced" DPT for students who are licensed pts ... The DPT graduate possesses clinical competence consistent with the preferred ... Doctor of Physical Therapy ( DPT ) Rehabilitation Science D...
Pts in Biological Technology

Zymes Omega Solutions Bottles and Launches the World's First Omega-3 Enhanced Water

...hill ( http://www.omegachill.com ). This innovative new water uses Zymes' pts technology to solubilize and stabilize fish-derived omega-3s. The resultin... Zymes Omega Solutions holds the world-wide exclusive rights for the use of pts for omega-3s for food, beverage and dietary supplements. For more informat...

OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer

...ber of Patients Alive (follow up ongoing) 16/81 (20%) Median Overall Survival 14.1 months (0.13-45.9) Number of pts Surviving Greater than or equal to 12 months 54% (43%-64%: 95% CI) Greater than or equal to 18 months(1) 39% (28%-4...

Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology

... Scale-up of Zymes' pts by Albemarle responds to the demand in food, bever...ificant GMP manufacturing capabilities to generate pts in quantities that accelerate its delivery for use...ned GRAS (Generally Recognized as Safe) status for pts following submission to the FDA. In addition to e...

Fufeng Announces 2008 Interim Results With Strong Sign of Recovery

...ecreased by 14.8% to RMB21,547 per tonne in the 1H of 2008. However, the gross profit ratio maintained at high level with a slight adjustment of 1.6 % pts in the 1H of 2008. Talking about the Group's future strategies, Mr. Li said, "It is expected that the market consolidation in MSG market will contin...

REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO

... Oral Presentation "A phase 1 study of XL184, a RET, VEGFR2, and MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC)" Day: Sunday, June 1 Session: Developmental Therapeutics: Molecular Therapeutics Time: 10-10:15 a....

Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing

...Presentation "A phase 1 study of XL184, a RET, VEGFR2, and MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC)" Day: Sunday, June 1 Session: Developmental Therapeutics: Molecular Therapeutics Time:...

Gala Biotech among companies sold for $3.3 billion

...eeded more focus than Cardinal Health could give it." Cardinal Health, an $81 billion company, announced in late 2006 that it planned to divest the pts segment to focus on healthcare provider customers like hospitals and pharmacies. Cardinal's pharmaceutical technologies and services units, which empl...

More>>

Pts in Biological Definition

Peroxisome

...nd in a peroxisome are imported from the cytosol . Each enzyme transferred to a peroxisome has a special sequence at one end of the protein, called a pts or peroxisomal targeting signal , that allows the protein to be taken into that organelle, where they then function to rid the cell of toxic substance...
Other Tags
(Date:7/13/2014)... Wa (PRWEB) July 13, 2014 According ... by Vkool.com, this is a comprehensive guide that features ... deal with KP (keratosis pilaris). This guide ... 1: What Is Keratosis Pilaris? ,     Chapter 2: ... I Know If I Have KP? ,     Chapter ...
(Date:7/12/2014)... Fadhits.com, a well-known wedding dress manufacturer and retailer, has added ... to its product line. In addition, the company has launched ... bring more benefits for its loyal fans. All its ... to 72% off. , As a leader in the garment ... is a good place for ladies who want to purchase ...
(Date:7/12/2014)... 12, 2014 The Passenger Information System ... 2013 to $20,341.36 million by 2019, at an expected ... 2019. , The public transport infrastructure in North America ... available in almost every corner of the region. The ... of public transport service providers are driving the North ...
(Date:7/12/2014)... 12, 2014 The report, "Phthalic Anhydride ... Market by Application & Geography – Trends & Forecast ... analysis and forecasting of market volume and value. The ... derivatives separately. The market of phthalic anhydride is projected ... to $8,415.89 million by 2018, with a CAGR of ...
(Date:7/12/2014)... Dallas, TX (PRWEB) July 12, 2014 ... training market research report, ‘cognitive assessment and ... able to monitor, assess, train, or enhance ... several uses such as in dementia screening, ... concussion management, classroom learning, self assessment, brain ...
Breaking Medicine News(10 mins):Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5
(Date:7/10/2014)... 2014  Pomerantz LLP has filed a class ... the "Company")(NYSE-MKT: PVCT) and certain of its officers.  ... Court, Middle District of Tennessee ... class consisting of all persons or entities who ... 17, 2013 and May 22, 2014, both dates ...
(Date:7/10/2014)... , July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric ... CEO Mr. Gino Pereira was interviewed on July ... Tampa Florida . Mr. Pereira discusses the ... Cedric Harris and how the Wocket™ aims to replace ... Cedric Harris tells Gino he has ...
(Date:7/10/2014)... Fingerprint Cards, (FPC,s) new mobile touch ... Asian OEM has selected FPC1021 for a flagship model with ...   FPC is proud to announce this DW ... for start of mass production in August 2014. FPC has ... delivery in the first half of July. The OEM wants ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
Other Contents